647 filings
S-3/A
LPCN
Lipocine Inc
Shelf registration (amended)
23 Apr 24
4:24pm
DEF 14A
LPCN
Lipocine Inc
Definitive proxy
23 Apr 24
4:05pm
8-K
LPCN
Lipocine Inc
11 Apr 24
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
7:24am
8-K
LPCN
Lipocine Inc
28 Mar 24
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
6:26am
8-K
LPCN
Lipocine Inc
25 Mar 24
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
6:14am
4
j899ok2je3vx qcgp3v9
12 Mar 24
Lipocine / Mahesh V. Patel ownership change
5:53pm
4
3crw3ilsg5 35q
12 Mar 24
Lipocine / Krista Fogarty ownership change
5:51pm
8-K
ar00om
7 Mar 24
Other Events
5:31pm
8-K
wv6c6n
7 Mar 24
Results of Operations and Financial Condition
6:08am
8-K
gkg5zw uvcdob
6 Mar 24
Lipocine to Present at 36th Annual Roth Conference
6:01am
8-K
3f292mnebqr
12 Feb 24
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
4:10pm
8-K
mb5pye933u9audifjqvi
18 Jan 24
Lipocine and Verity Pharma Enter into License Agreement
8:20am
8-K
zcadmt0q0u jm5ne47
8 Jan 24
Other Events
6:35pm
8-K
ilzp3j26pnco4xy1zfh
19 Dec 23
Lipocine to Present at Biotech Showcase 2024
10:00am
8-K
w871c np6
13 Nov 23
Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver MeetingĀ® 2023
2:45pm
8-K
bzoi8opxb9wt4s
8 Nov 23
Other Events
9:50am
8-K
nypx24ti ovh2edm8hq0
1 Nov 23
Lipocine to Present Clinical Data on LPCN 1148 at The Liver MeetingĀ® 2023
9:31am